Skip to main content
. 2020 Feb 17;43(4):1081–1088. doi: 10.3892/or.2020.7505

Figure 5.

Figure 5.

Clinical outcomes of patients with T4 tumors who underwent curative gastrectomy of the T4 tumor. Patients were divided into miR-29s ‘high’ and ‘low’ groups based on the median values. Survival rates were calculated using the Kaplan-Meier method and differences were evaluated using the log-rank test. Peritoneal (A-C) recurrence-free survival and (D-F) overall survival in patients with low and high expression of miR-29a-3p, miR-29b-3p, miR-29c-3p respectively.